Concorde Asset Management’s Twist Bioscience TWST Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | $315K | Sell |
7,822
-1,594
| -17% | -$64.2K | 0.17% | 105 |
|
|
2024
Q4 | $438K | Sell |
9,416
-1,490
| -14% | -$69.2K | 0.23% | 77 |
|
|
2024
Q3 | $493K | Sell |
10,906
-495
| -4% | -$22.4K | 0.28% | 64 |
|
|
2024
Q2 | $562K | Sell |
11,401
-1,512
| -12% | -$74.5K | 0.35% | 52 |
|
|
2024
Q1 | $443K | Buy |
12,913
+1,271
| +11% | +$43.6K | 0.3% | 60 |
|
|
2023
Q4 | $429K | Sell |
11,642
-101
| -0.9% | -$3.72K | 0.29% | 66 |
|
|
2023
Q3 | $238K | Buy |
+11,743
| New | +$238K | 0.21% | 116 |
|